GSDME and colorectal carcinoma: The methylation inhibitor 5-aza-2′-deoxycytidine (5-aza-dC) could promote GSDME expression and inhibit tumor cell proliferation and carcinogenesis, implying that GSDME is a potential tumor suppressor gene in CRC [73,84].